Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapine

R.P.G. van Heeswijk, A.I. Veldkamp, J.W. Mulder, P.L. Meenhorst, J.H. Beijnen, R.M.W. Hoetelmans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)255-258
Number of pages4
JournalTherapeutic Drug Monitoring
Volume23
Publication statusPublished - 2001

Cite this